Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Hradek, Alex C. | Lee, Hyun-Pil | Siedlak, Sandra L. | Torres, Sandy L. | Jung, Wooyoung | Han, Ashley H. | Lee, Hyoung-gon; *
Affiliations: Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA
Correspondence: [*] Correspondence to: Hyoung-gon Lee, PhD, Department of Pathology, Case Western Reserve University School of Medicine, 2103 Cornell Road, Cleveland, OH 44106, USA. Tel.: +1 216 368 6887; Fax: +1 216 368 8964; E-mail: [email protected].
Abstract: Cell cycle re-entry in Alzheimer's disease (AD) has emerged as an important pathological mechanism in the progression of the disease. This appearance of cell cycle related proteins has been linked to tau pathology in AD, but the causal and temporal relationship between the two is not completely clear. In this study, we found that hyperphosphorylated retinoblastoma protein (ppRb), a key regulator for G1/S transition, is correlated with a late marker for hyperphosphorylation of tau but not with other early markers for tau alteration in the 3xTg-AD mouse model. However, in AD brains, ppRb can colocalize with both early and later markers for tau alterations, and can often be found singly in many degenerating neurons, indicating the distinct development of pathology between the 3xTg-AD mouse model and human AD patients. The conclusions of this study are two-fold. First, our findings clearly demonstrate the pathological link between the aberrant cell cycle re-entry and tau pathology. Second, the chronological pattern of cell cycle re-entry with tau pathology in the 3xTg-AD mouse is different compared to AD patients suggesting the distinct pathogenic mechanism between the animal AD model and human AD patients.
Keywords: Alzheimer's disease, animal model, cell cycle, retinoblastoma protein (Rb), tau, transgenic mouse
DOI: 10.3233/JAD-141083
Journal: Journal of Alzheimer's Disease, vol. 43, no. 1, pp. 57-65, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]